Compare INBX & UMAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | INBX | UMAC |
|---|---|---|
| Founded | 2010 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 430.2M | 393.5M |
| IPO Year | 2020 | 2024 |
| Metric | INBX | UMAC |
|---|---|---|
| Price | $79.02 | $11.69 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | N/A | ★ $20.00 |
| AVG Volume (30 Days) | 242.1K | ★ 2.2M |
| Earning Date | 11-14-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $1,400,000.00 | ★ $8,304,873.00 |
| Revenue This Year | $563.00 | $84.19 |
| Revenue Next Year | N/A | $166.17 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 133.20 |
| 52 Week Low | $10.81 | $4.45 |
| 52 Week High | $94.57 | $21.65 |
| Indicator | INBX | UMAC |
|---|---|---|
| Relative Strength Index (RSI) | 48.06 | 55.39 |
| Support Level | $76.22 | $8.66 |
| Resistance Level | $94.57 | $13.35 |
| Average True Range (ATR) | 6.98 | 1.00 |
| MACD | -1.37 | 0.35 |
| Stochastic Oscillator | 21.45 | 63.97 |
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.
Unusual Machines Inc is engaged in serving the American drone industry by building and selling drone components.